How is the Synaptogenix Inc today?

The Synaptogenix Inc today is trading in the green, up by 15.09% at 4.27.

How has Synaptogenix Inc performed historically?

The Synaptogenix Inc is currently trading up 15.09% on an intraday basis in the past week the index rose 77.18%. The index has been up 56.99% in the past quarter and fell -7.38% in the past year. You can view this in the overview section.

What is Synaptogenix Inc Annual Net Profit?

Synaptogenix Inc Annual Net Profit fell 111.45% in the last year to $12.77 M. Its sector's average net profit growth for the last fiscal year was -14.01%.

What is Synaptogenix Inc Price to Earning Ratio?

Synaptogenix Inc Price to Earning Ratio is -0.49, which is negative.

What is Synaptogenix Inc Stock Price?

Synaptogenix Inc Stock Price fell 7.38% and underperformed its sector by 18.3% in the past year.

What is Synaptogenix Inc Quarterly Net profit?

Synaptogenix Inc Quarterly Net profit rose 286.34% YoY to $0.39 M. Its sector's average net profit growth YoY for the quarter was -236.8%.

What is Synaptogenix Inc Return on Equity(ROE)?

Synaptogenix Inc Return on Equity(ROE) for the last financial year was -89.76%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Synaptogenix Inc Mutual Fund Holding?

Synaptogenix Inc Mutual Fund Holding increased by 0.01% in the last quarter to 1.25.

What is Synaptogenix Inc Institutional Holding?

Synaptogenix Inc Institutional Holding increased by 2.03% in the last quarter to 5.4.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
SYNAPTOGENIX INC

Synaptogenix Inc XNAS: SNPX

Synaptogenix Inc Live Share Price Today, Share Analysis and Chart

Name: Synaptogenix Inc: Is Infosys Ltd. worth buying?
Item: Synaptogenix Inc
Rating: 1.90433325
Author: Trendlyne DVM scores

about

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer'...

4.27 0.56 (15.09%)

New 52W High in past week

247.2K

XNAS Volume

XNAS 16 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

11.3 / 100

Technically Moderately Bullish

64.8 / 100

No estimates available

Synaptogenix Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Synaptogenix Inc Live Share Price Today, Share Analysis and Chart

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer'...

New 52W High in past week

SWOT Analysis

Synaptogenix Inc Live Price Chart

Synaptogenix Inc FAQ

How is Synaptogenix Inc today?

Synaptogenix Inc today is trading in the green, and is up by 15.09% at 4.27.

How has Synaptogenix Inc performed historically?

Synaptogenix Inc is currently trading up 15.09% on an intraday basis. In the past week the stock rose 77.18%. stock has been up 56.99% in the past quarter and fell -7.38% in the past year. You can view this in the overview section.